Detalhe da pesquisa
1.
Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
PLoS Med
; 18(12): e1003876, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34905549
2.
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
PLoS Med
; 18(8): e1003734, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464388
3.
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
PLoS Med
; 18(8): e1003732, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464379
4.
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.
medRxiv
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293154
5.
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.
NPJ Precis Oncol
; 7(1): 6, 2023 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658307
6.
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer.
medRxiv
; 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077092
7.
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.
NPJ Precis Oncol
; 7(1): 105, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37857854
8.
ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250420
9.
Cell-free DNA alterations in the AR enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancer.
JCO Precis Oncol
; 4: 680-713, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32903952